Menu

Allergan

Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign – Toilet Talk

, , , ,

In Recognition of IBS Awareness Month, Allergan and the American Gastroenterological Association Work to Destigmatize the Bowel Health Conversation DUBLIN, April 7, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a global pharmaceutical company and leader in developing best-in-class treatment options for patients, has partnered with the American Gastroenterological Association (AGA), to announce the launch of […]

Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy

, , , ,

DUBLIN, April 6, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Daphne Karydas will join the Company as Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017. In this role, Ms. Karydas will lead the Company’s engagement with the investment community, and will work […]

Allergan Announces U.S. Availability of VIBERZI™ (eluxadoline) for Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults

, , ,

– VIBERZI is a First-In-Class, Proactive Treatment Option for Adults Suffering From IBS-D DUBLIN, Dec. 14, 2015 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced today that VIBERZI™ (eluxadoline), the company’s first-in-class treatment for irritable bowel syndrome with diarrhea (IBS-D), is now available by prescription in the U.S. “We are excited […]

1 2